文献速递脑血管病

发病方式改变急性缺血性卒中血管内再灌注时间对临床结局的影响:DAWN试验分析

Mode of Onset Modifies the Effect of Time to Endovascular Reperfusion on Clinical Outcomes after Acute Ischemic Stroke: An Analysis of the DAWN Trial.
PubMed 文献 · Ann Neurol · 2024-06-15

基于DAWN试验205例患者,评估血管内取栓时间延迟与90天功能独立、症状性颅内出血和死亡的关系,并探索发病方式的效应修饰。总体取栓组和药物治疗组中时间延迟与结局无显著关联,但取栓组中从最后正常时间至成功再灌注的关联与发病方式存在显著交互作用(p=0.013),醒后卒中患者斜率显著为负(p=0.018)。

要点

  • DAWN试验205例中,98例(47.8%)在6至12小时时间窗,107例(52.2%)在12至24小时时间窗。
  • 总体人群中,从最后正常时间至随机化每延迟1小时与90天功能独立或死亡无显著关联。
  • 取栓组中,从最后正常时间至成功再灌注与90天功能独立的关联受发病方式显著修饰(p=0.013)。

核心结论

  • 发病方式修饰再灌注时间对取栓结局的影响,在延长时间窗探索不同治疗范式时应考虑发病方式。

研究设计与样本

  • DAWN试验分析,纳入205例患者,评估每1小时治疗延迟与90天功能独立(改良Rankin量表评分0-2)、症状性颅内出血和90天死亡的关系,并在总体人群和三种发病方式亚组(醒后卒中 vs 目击卒中 vs 未目击卒中)中探索。

主要发现

  • 取栓组每延迟1小时与功能独立(改良Rankin量表评分0-2)的OR为1.07(95%CI 0.93-1.24),与死亡(改良Rankin量表评分6)的OR为0.84(95%CI 0.65-1.03)。
  • 药物治疗组每延迟1小时与功能独立(改良Rankin量表评分0-2)的OR为0.98(95%CI 0.80-1.14),与死亡(改良Rankin量表评分6)的OR为0.94(95%CI 0.79-1.09)。
  • 治疗效应与时间无显著交互作用(功能独立p=0.439,死亡p=0.421)。
  • 取栓组中,从最后正常时间至成功再灌注(改良脑梗死溶栓分级≥2b)与90天功能独立的关联与发病方式存在显著交互作用(p=0.013),醒后卒中患者斜率显著为负(p=0.018),目击卒中和未目击卒中患者斜率名义上为正。
  • 治疗时间与症状性颅内出血无关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to assess the impact of time to endovascular thrombectomy (EVT) on clinical outcomes in the DAWN trial, while also exploring the potential effect modification of mode of stroke onset on this relationship. METHODS: The association between every 1-h treatment delay with 90-day functional independence (modified Rankin Scale [mRS] score 0-2), symptomatic intracranial hemorrhage, and 90-day mortality was explored in the overall population and in three modes of onset subgroups (wake-up vs. witnessed vs. unwitnessed). RESULTS: Out of the 205 patients, 98 (47.8%) and 107 (52.2%) presented in the 6 to 12 hours and 12 to 24 hours time window, respectively. Considering all three modes of onset together, there was no statistically significant association between time last seen well to randomization with either functional independence or mortality at 90 days in either the endovascular thrombectomy (mRS 0-2 1-hour delay OR 1.07; 95% CI 0.93-1.24; mRS 6 OR 0.84; 95% CI 0.65-1.03) or medical management (mRS 0-2 1-hour delay OR 0.98; 95% CI 0.80-1.14; mRS 6 1-hour delay OR 0.94; 95% CI 0.79-1.09) groups. Moreover, there was no significant interaction between treatment effect and time (p = 0.439 and p = 0.421 for mRS 0-2 and 6, respectively). However, within the thrombectomy group, the models that tested the association between time last seen well to successful reperfusion (modified Treatment in Cerebral Infarction ≥2b) and 90-day functional independence showed a significant interaction with mode of presentation (p = 0.013). This appeared to be driven by a nominally positive slope for both witnessed and unwitnessed strokes versus a significantly (p = 0.018) negative slope in wake-up patients. There was no association between treatment times and symptomatic intracranial hemorrhage. INTERPRETATION: Mode of onset modifies the effect of time to reperfusion on thrombectomy outcomes, and should be considered when exploring different treatment paradigms in the extended window. ANN NEUROL 2024;96:356-364.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Nogueira RG, Doheim MF, Jadhav AP, et al. Mode of Onset Modifies the Effect of Time to Endovascular Reperfusion on Clinical Outcomes after Acute Ischemic Stroke: An Analysis of the DAWN Trial. Ann Neurol. 2024. PMID: 38877793. doi:10.1002/ana.26968

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。